Ballicules.com

Darifenacin and Bethanechol: a Muscarinic M3 receptor interaction

Darifenacin blocks the muscarinic M3 receptor, so Bethanechol cannot act there — the effect of Bethanechol is reduced or lost.

Bethanechol is an agonist at the muscarinic M3 receptor: it binds and switches the receptor on. Darifenacin is an antagonist at the same site and switches nothing on. With both present they compete for the same pocket, and whichever is there in greater effective concentration decides what the receptor does.

Given together they work against whatever each was started for. If both are genuinely needed, expect less of Bethanechol’s effect than its dose would suggest.

This is a pharmacodynamic interaction. Neither drug changes the other’s concentration, so a level, an AUC estimate or a genotype looks entirely normal while the clinical effect is blunted.

The direction can be the useful one. The same opposition is what makes a reversal agent, an antidote or a planned antagonist work.

Darifenacin versus Bethanechol over the Muscarinic M3 receptor
Fight club: Darifenacin versus Bethanechol — Muscarinic M3 receptor

The two ballicules, with the Muscarinic M3 receptor lit on each

Darifenacin ballicule, with its Muscarinic M3 receptor peg ringed
Darifenacin (ENABLEX)
Muscarinic M3 receptor antagonist
Bethanechol ballicule, with its Muscarinic M3 receptor peg ringed
Bethanechol (URECHOLINE)
Muscarinic M3 receptor agonist

The ring marks the peg each drug wears for this receptor — the same cross-illumination Interact! draws when the two are put side by side.

The mascots

Darifenacin mascot mnemonic cartoon
Darifenacin
Fenced-in Dairy Enabler
Bethanechol mascot mnemonic cartoon
Bethanechol
Bath of ‘choline / Urine ‘choline

Open it in the console